In vivo ViroMag Transduction Reagent has been designed for in vivo targeted transduction with any viral vector. Virus/nanoparticles complexes can be easily administrated through various injection routes such as systemic administration (intravenous, intra-artery) or local administration (intratumoral, intracerebroventricular).
- In vivo Transduction™ main advantages in comparison to other procedures:
- High and increased transduction / infection efficiency
- Magnetically targeted transduction to specific area
- Reduction of virus dose and systemic dissemination
- Work under non permissive conditions (hypothermia, physiological flow conditions)
- Penetration of the vector into tissues
- Minimized toxicity
- Suitable for all types of viruses
- The In vivo ViroMag Trial Kit includes 50 ul of in vivo ViroMag and a cylinder magnet.